Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

12. Misc. & Small but Mighty Scouting Reports

12. Misc. & Small but Mighty Scouting Reports

FromRheumMadness Podcast


12. Misc. & Small but Mighty Scouting Reports

FromRheumMadness Podcast

ratings:
Length:
23 minutes
Released:
Mar 19, 2021
Format:
Podcast episode

Description

In this episode, the fantastic Dr. Lisa Criscione-Schreiber (crucial mentor for the RheumMadness team) reads out the scouting reports for the Miscellaneous and Small but Mighty regions of the tournament.   Feel free to skip this episode if you've already read the reports.  Find the reports and learn more about RheumMadness here: https://sites.duke.edu/rheummadness/Scouting reports included in this episode:IgG4-RD Classification Criteria, written by the Massachusetts General Hospital Adult Rheumatology Fellowship Program; Guy Katz, MD; Ian Cooley, MD; Duncan F Moore, MD; Naomi Patel, MDRelapsing Polychondritis Subtypes, written by the Wake Forest School of Medicine Adult Rheumatology Fellowship Program; Page Bomar, Rami Diab, John Herion, Yael KlionskyAnti-CD38 in Refractory Lupus, written by the University of North Carolina Adult Rheumatology Fellowship Program; Leah Bettner, Shruti Chandramouli, Amanda Lusa, Christopher Overton, and Enid SunVEXAS, written by the RheumMadness Leadership TeamIntro and Outro music:Cheery Monday by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3495-cheery-mondayLicense: http://creativecommons.org/licenses/by/4.0/
Released:
Mar 19, 2021
Format:
Podcast episode

Titles in the series (32)

The RheumMadness podcast is part of a rheumatology learning initiative sponsored by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award. Dr. Leverenz has also received grant funding from Pfizer for quality improvement work unrelated to RheumMadness.